Advocacy Actions
European Chamber Shanghai Board Chairman Speaks at Business Forum for European Business Delegates Accompanying AGRI Commissioner Phil Hogan to China
European Chamber Shanghai Board Chairman Speaks at Business Forum for European Business Delegates Accompanying AGRI Commissioner Phil Hogan to China
Read moreParticipate CMDE Seminar on draft MSW QMS audit guidance
Participate seminar of CMDE for developing a guidance of medical software quality management system audit
Read moreMeeting with Shanghai Financial Services Office on Opening-up of Banking Sector
Meeting with Shanghai Financial Services Office on Opening-up of Banking Sector
Read moreComments on standard of UDI to CMDSA
Comments on Standard of Unique Device Identification were submitted to Center for Medical Device Standardization Administration (CMDSA)
Read moreInformation to CMDE's Inquiry on 'Urgently Required Medical Devices'
On request of the Centre of Medical Device Evaluation (CMDE), the Healthcare Equipment (HCE) submitted information on medical devices urgently required by Chinese hospitals.
Read moreMeeting with the Hunan HFPC on Local Implementation of the Healthcare Reform
A delegation of the Healthcare Equipment (HCE) Working Group met Mr Chen Xiaochun, director of Hunan HFPC and four of heads of department to discuss the local implementation of the healthcare reform.
Read moreMeeting with Shanghai Municipal Government Development and Research Center on 2018 Shanghai Think Tank Summit
Meeting with Shanghai Municipal Government Development and Research Center on 2018 Shanghai Think Tank Summit
Read moreIMDRF Clinical Evaluation WG meeting
International Medical Device Regulators Forum (IMDRF) Clinical Evaluation Working Group meeting
Read moreMeeting with International Trade Committee of the European Parliament
The European Chamber led by President Mats Harbon met with a delegation of the INTA Committee led by its chairperson, Mr Bernd Lange. The purpose of the meetings was to have an open discussion on EU-China relations and the business environment for European companies in China.
Read moreAdvocacy Letter to China National Drug Administration on Recommendation on the Management Adjustment to the Pudong Pilot Programme
The European Chamber’s Cosmetics working groups submitted an advocacy letter to CNDA tore commend, based on the Pudong Pilot Program and under the guidance of the CNDA, Shanghai FDA, and by the implementation of Pudong Market Supervision Administration, before the program ends in 2018, a product safety evaluation report be used to replace animal testing in the materials submitted to notify an imported non-functional cosmetic product. This evaluative form can only be valid on the condition that the ‘responsible person’ (a term denoting corporate responsibility) will undertake all responsible precautionary measures to guarantee a product is safe and of good quality, to ensure a competent quality management system is established and to make sure onsite inspections of overseas manufacturing is doable.
Read more